Efficacy of Cetuximab in Combination with FOLFIRI in a Patient with KRAS Wild-Type Metastatic Anal Cancer

Anal canal cancer is a rare tumor without clear treatment evidence in the metastatic setting. In terms of the bad prognosis of patients with metastatic anal cancer, further therapeutic options are urgently needed. In this paper we present the case of a 64-year-old man suffering from undifferentiated...

Descripción completa

Detalles Bibliográficos
Autores principales: Barmettler, Hanna, Komminoth, Paul, Schmid, Mathias, Duerr, Donat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2012
Materias:
Published online: August, 2012
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3432997/
https://www.ncbi.nlm.nih.gov/pubmed/22949905
http://dx.doi.org/10.1159/000341371

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3432997/
https://www.ncbi.nlm.nih.gov/pubmed/22949905
http://dx.doi.org/10.1159/000341371

Ejemplares similares